Skip to main content
Clinical Trials/IRCT20141209020258N93
IRCT20141209020258N93
Recruiting
Phase 2

Comparison of therapeutic effects and its outcomes with morphine against methadone in combination with diazepam and haloperidol in cancer patients with severe and chronic pain referred to emergency ward.

Vice Chancellor For Research, Arak University Of Medical Science0 sites92 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Vice Chancellor For Research, Arak University Of Medical Science
Enrollment
92
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor For Research, Arak University Of Medical Science

Eligibility Criteria

Inclusion Criteria

  • All patients with metastatic disease of spine with pain complaints and scurvy of pain 7 and above referring to Emergency hospital of Amiralmomenin and Vali Asr arak Hospital
  • Non\-allergic to benzodiazepine and haloperidol

Exclusion Criteria

  • Unsatisfied patients
  • Decreased consciousness at the time of referral or during the study
  • Blood pressure drop of SBP \<90 at the time of referral or during the study
  • There is any contraindication in the administration of opioid or Benzodiazepine or Haloperidol
  • Patients with scores of pain less than 7
  • Oxygen saturation below 92%
  • Heart rate above 90 or under 60

Outcomes

Primary Outcomes

Not specified

Similar Trials